Pfizer to acquire sickle cell disease specialist for $5.4b USD August 8, 2022 AutoBot Markets & Regulations 0 Biopharmaceutical company Global Blood Therapeutics specializes in conditions that often disproportionately impact underrepresented communities, such as SCD.